| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 13 Aug 2026 | 31 Jul 2026 |
| Sunil Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 inter alia to consider and approve Board Meeting scheduled to be held on 13.08.2026 pursuant to Regulation 29 read with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 inter alia to consider approve and take on record the Un-Audited Financial Results (both standalone and consolidated) for the 1st quarter of FY 2026-27 ended on June 30 2026. | ||
| Board Meeting | 29 May 2026 | 19 May 2026 |
| Sunil Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 inter alia to consider and approve Meeting of the Board of Directors of the Company is scheduled to be held on Friday May 29 2026 at Registered office 38E/252A Vijay Tower 3rd Floor Panchsheel Commercial Complex Shahpur Jat New Delhi-110049 (deemed venue) through video conferencing/Audio visual connection inter alia to consider approve and take on record the Audited Financial Results (both standalone and consolidated) for the 4th quarter of FY 2025-26 and for the Financial year 2025-26 ended on March 31 2026. Approved Audited Financial Results (Standalone and Consolidated) for the quarter/year ended March 31, 2026 (As per BSE Announcement dated on: 29.05.2026) | ||
| Board Meeting | 6 Feb 2026 | 28 Jan 2026 |
| Sunil Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2026 inter alia to consider and approve Intimation of Board Meeting scheduled to be held on 6th February 2026 to consider interalia un-audited financial results (standalone and consolidated) for the 3rd quarter/9 months ended 31.12.2025 of FY 2025-26 Board at its meeting held today interalia approved Unaudited Financial Results (both standalone and consolidated) for the quarter and nine months ended 31.12.2025 of FY 2025-26 (As Per BSE Announcement Dated on: 06/02/2026) | ||
| Board Meeting | 4 Nov 2025 | 24 Oct 2025 |
| Sunil Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2025 inter alia to consider and approve Board Meeting of the Company is scheduled to be held on Tuesday 4th November 2025 to consider interalia the un-audited financial results (standalone and consolidated) of the Company for the quarter/half year ended 30th September 2025. Board of Directors at its meeting held today on 04.11.2025 interalia approved Unaudited Financial results (both standalone and consolidated) for the quarter/half year ended 30.09.2025 (As Per BSE Announcement Dated on: 04/11/2025) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
